CBALX
Price
$52.41
Change
-$0.48 (-0.91%)
Updated
Jun 13 closing price
Net Assets
9.61B
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

CBALX vs RLBGX

Header iconCBALX vs RLBGX Comparison
Open Charts CBALX vs RLBGXBanner chart's image
Columbia Balanced Inst
Price$52.41
Change-$0.48 (-0.91%)
VolumeN/A
Net Assets9.61B
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
CBALX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBALX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBALX is a StrongBuy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. CBALX (9.61B). RLBGX pays higher dividends than CBALX: RLBGX (2.23) vs CBALX (2.02). CBALX was incepted earlier than RLBGX: CBALX (34 years) vs RLBGX (16 years). CBALX (0.68) is less costly to investors than RLBGX (0.25). CBALX is a more actively managed with annual turnover of: 200.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than CBALX: RLBGX (250) vs CBALX (2000). RLBGX annual gain was more profitable for investors over the last year : 5.63 vs. CBALX (1.64). RLBGX return over 5 years is better than : 40.35 vs. CBALX (30.08).
CBALXRLBGXCBALX / RLBGX
Total Expense Ratio0.680.25272%
Annual Report Gross Expense Ratio0.680.25272%
Fund Existence34 years16 years-
Gain YTD2.7704.59260%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets9.61B244B4%
Annual Yield % from dividends2.022.2390%
Returns for 1 year1.645.6329%
Returns for 3 years31.4333.7893%
Returns for 5 years30.0840.3575%
Returns for 10 years55.7060.8792%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp